On Friday, a Craig-Hallum analyst increased the price target for Harrow Health (NASDAQ: NASDAQ:HROW) shares to $30.00, up from the previous $26.00, while maintaining a Buy rating on the stock. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results